A Prospective Randomized, Double-Blind Comparison of LY900014 to Humalog with an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents with Type 1 Diabetes PRONTO-Peds

Study Overview

The study medication for this research study is called LY900014.  It is a type of mealtime insulin.  The main reason for you to take part in this study is not to treat you for your diabetes but to help in answering the following research questions:

•Does LY900014 help to lower blood glucose levels in patients with type 1 diabetes?

•How LY900014 controls blood glucose levels compared to Humalog.

 


  • IRB Number: 1906588741
  • Research Study Identifier: TX10572
  • Principal Investigator: Linda DiMeglio, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176